Clinical Trial Update: POSitron Emission Imaging Using 18F-FDOPA in Neurooncology [NA]

View source ↗

Summary

This clinical trial update reports on a study evaluating PET imaging with 18F-FDOPA for glioblastoma in neuro-oncology. The trial status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• 18F-FDOPA (fluorodopa (18F))

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Glioblastoma | NA | Status: COMPLETED